Contact
Assistant
This webinar will bring together leading experts, researchers, and industry professionals to discuss cutting-edge developments in advanced materials, additive manufacturing, digital twins, and smart manufacturing systems.
U.S. manufacturing is at a transformational moment as the country embarks on an ambitious agenda to rebuild its industrial base. Supply chain priorities, climate threats, a changing geopolitical landscape, technological advances, and a new trajectory in public policy are leading to breakthrough innovations and significant investments in domestic manufacturing. Across core industries – transportation, semiconductors, defense, energy, and materials– there is a generational shift in U.S. manufacturing toward greater resilience, digitalization, and sustainability. Liz Reynolds will provide an overview of the recent changes that are impacting the U.S. industrial base and the implications for U.S. manufacturing going forward.
Risk, Innovation and the New Manufacturing Pioneers
Ben Armstrong Executive Director, MIT Industrial Performance Center
Immune homeostasis requires constant collaboration between a diverse and dynamic set of cell types. Within our immune tissues, distinct cellular subsets must work together to defend against pathogenic threats, maintain tolerance, and establish memory. While surveying multiple healthy individuals enables exploration of potential ensemble immune solutions, contrasts against outliers of health and disease can reveal deviations that underscore diagnostic, therapeutic, and prophylactic features of enhanced function or dysfunction. Here, I will discuss how we can leverage single-cell genomic approaches – and, in particular, single-cell RNA-Seq – to explore the extensive functional diversity among immune cells within and across individuals, and uncover, from the bottom-up, distinct cell types and states associated with improved immunity. Moreover, I will discuss emerging experimental and computational strategies for altering ensemble cellular responses through targeted intra- or extracellular induction of these preferred types and states.